Scapa Healthcare

What Scapa Healthcare does

Scapa Healthcare is a contract development and manufacturing organization (CDMO) that designs, develops, and manufactures medical-grade skin contact adhesives and skin care topical solutions for OEM customers in the healthcare and consumer industries. Its product platform is anchored by the proprietary Scapa Soft-Pro® Adhesive family across four chemistries - hydrocolloid, hydrogel, acrylic, and silicone gel - and by the Bioflex Materials portfolio of substrates (collagen, films, foams, sponges, nonwovens), supplemented by Skin Care Topicals and proprietary design platforms such as FlexCore, FlexPore, and MEDIFIX Solutions. End-use applications span advanced wound care, consumer wellness (consumer bandages, OTC skin care), and medical device fixation for wearables such as continuous glucose monitors and pulse oximeters.

The company operates a fully vertically integrated service model spanning R&D, formulation, adhesive coating, converting and assembly, liquids and powders filling, printing, packaging, microbiology testing, regulatory affairs, and on-site gamma irradiation sterilization. Manufacturing and Centers of Excellence are located in Dallas TX (North America Center of Excellence), Knoxville TN, Orangeburg NY, Windsor CT, and Gargrave, UK (European Center of Excellence with on-site gamma plant), with commercial presence extending into South America and Asia. Revenues are generated through two streams: contract development and manufacturing services charged to OEM customers (B2B professional services model with quote-based, undisclosed pricing) and market-ready / turnkey solutions that customers can quickly brand and launch. Distribution is direct enterprise sales to leading global medtech and consumer companies.

Scapa Healthcare is a privately held business unit of Mativ Holdings, Inc. (NYSE: MTIV, formerly SWM International), having been acquired as part of the April 2021 purchase of Scapa Group plc. The division was assembled through the prior acquisition of Biomed Laboratories (Dallas) in 2018 to add topical formulation capabilities, and the Gargrave, UK acquisition to establish the European footprint. John Petreanu has served as President since May 2020. The company holds ISO 13485 certification and has at least one FDA 510(k)-cleared wound care product, supporting its positioning as a regulated medical device outsourcing partner.

Name

Scapa Healthcare

Legal name

Scapa Healthcare

Website

https://scapahealthcare.com

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Scapa Healthcare is a contract development and manufacturing organization (CDMO) that designs, develops, and produces medical-grade skin contact adhesives and topical skin care solutions for OEM healthcare and consumer companies, serving advanced wound care, consumer wellness, and wearable medical device fixation markets.

Ownership category

akta.pro rank

Product category

Medical Adhesive Contract Manufacturing

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (33911)

SIC

Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Drug Substance–Drug Product Integrated CDMO (HLAGABAG)

akta.pro secondary industries

Sterile Fill-Finish & Aseptic Manufacturing CDMO (HLAGABAH), Packaging, Labeling & Serialization (Clinical/Commercial) CDMO (HLAGABAJ)

Keywords

• Medical adhesive manufacturing
• Contract development manufacturing
• Wound care solutions
• Medical device fixation
• Skin contact adhesives

Headquarters

HQ city

Marlborough

HQ country

United Kingdom

HQ region

Europe

Offices5 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Contract Manufacturing Services: Scapa Healthcare operates as a strategic outsource partner providing end-to-end contract development and manufacturing services for healthcare and consumer companies. Revenue is generated through design, development, and manufacturing services including formulation, coating, converting, assembly, filling, printing, packaging, and sterilization.
2. Market-Ready Solutions: Sale of pre-formulated, market-ready products including consumer bandages, advanced wound dressings, ostomy supplies, and device fixation products for quick branding and market introduction.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Scapa Healthcare is a B2B contract development and manufacturing organization (CDMO) that designs, develops, and manufactures medical-grade skin contact adhesives, advanced wound care materials, and skin care topical solutions for healthcare and consumer companies. The company provides end-to-end capabilities from formulation and R&D through adhesive coating, converting, assembly, packaging, and sterilization, offering both custom development and market-ready products across advanced wound care, consumer wellness, and medical device fixation markets.

Product overview

Scapa Healthcare is a contract development and manufacturing organization (CDMO) offering a comprehensive portfolio of medical-grade skin contact adhesives, advanced materials, and skin care topical solutions. The company's core products center on the Scapa Soft-Pro® Adhesives line (including hydrocolloids, hydrogels, acrylics, and silicone gels) and Bioflex Materials. Their market-ready solutions include consumer bandages, advanced wound dressings, ostomy supplies, and device fixation products. The company also offers design technologies such as FlexCore, FlexPore, and MEDIFIX Solutions. Manufacturing capabilities encompass adhesive coating, converting & assembly, printing, packaging, and sterilization services. Support services include formulation development, microbiology testing, and regulatory affairs. Scapa Healthcare operates across advanced wound care, consumer wellness, and medical device fixation markets, serving as a strategic outsource partner for leading healthcare and consumer companies.

Differentiator

Problem solved

Functional benefit

Brands

• Scapa Soft-Pro® Adhesives: Medical-grade skin contact adhesive product line including silicone gels, hydrogels, hydrocolloids, and acrylics.
• Bioflex Materials

Products and services

• Scapa Soft-Pro Adhesives Comprehensive portfolio of medical-grade skin contact adhesives for medical device fixation, including silicone gels, hydrogels, hydrocolloids, and acrylics for short-term to long-term wear applications.
• Bioflex Materials Range of medical substrates including collagen, films, foams, sponges and nonwovens supplied with different adhesive technologies for wound care, ostomy, medical devices and consumer fixation.
• Skin Care Topicals Custom topical wound care solutions and consumer skin care products with optimal dosage levels of active ingredients, including wound care treatments, ostomy and incontinence care, professional and OTC skin care, and first-aid products.
• Hydrocolloid Advanced Dressings Ready-to-market advanced wound care dressings using hydrocolloid technology for professional healthcare settings.
• Hydrogel Advanced Dressings Ready-to-market advanced wound care dressings using hydrogel technology for professional healthcare settings.
• Hydrocolloid Consumer Bandages Ready-to-market hydrocolloid-based consumer bandage products for wound protection and healing.
• Hydrogel Consumer Bandages Ready-to-market hydrogel-based consumer bandage products for minor wound care and protection.
• Ostomy Supplies and Accessories Ready-to-market ostomy products including hydrocolloid-based accessories, stoma pastes, flange extenders, and skin barrier products for ostomy care.
• Device Fixation Solutions Ready-to-market medical device fixation solutions for wearable medical devices and continuous monitoring applications.
• Adhesive Coating Services Contract manufacturing services for adhesive coating on various substrates using Scapa Soft-Pro adhesive technologies.
• Converting and Assembly Services Fully integrated adhesive converting and assembly solutions including multi-layer laminating, cutting, thermal laminating, and automated assembly for medical devices.
• Printing Services Printing capabilities for creating unique designs and functional printing to aid with registration and assembly of medical devices.
• Packaging Services Complete packaging solutions for medical devices and healthcare products.
• Sterilization Services Gamma irradiation services for medical devices, pharmaceutical and consumable products with different densities, dose requirements, and material composition.
• Formulation, Compounding and Blending Services Custom formulation development and manufacturing of topical wound care solutions and consumer skin care products with optimal dosage levels of active ingredients.
• Microbiology Testing Services Comprehensive microbiology laboratory services including bioburden validation, sterility testing, and sterilization dose mapping and substantiation.
• Regulatory Affairs Services Regulatory affairs support to help customers navigate compliance requirements for medical devices and healthcare products.

Quantifiable outcome

• Supply chain risk mitigation through vertically integrated, near-shore capabilities

Segments3 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• SWM International (Mativ)flagshipStrategic or Co-development PartnerScapa Healthcare was acquired by Mativ (formerly SWM International), becoming a Mativ brand. Mativ is described as a worldwide leader in speciality materials. The acquisition positions Scapa Healthcare as part of a larger global materials company with expanded capabilities and resources.

Scale indicators2 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Avery Dennison Medical: Avery Dennison's medical materials business manufactures pressure-sensitive adhesives, tapes, and wearable component solutions for medical device fixation, wound care, and ostomy applications. It is one of Scapa's closest direct competitors in medical-grade skin contact adhesives and OEM contract manufacturing.
• Mölnlycke Health Care: Mölnlycke is a global wound care and surgical solutions specialist with a deep portfolio in advanced dressings, single-use surgical products, and topical solutions. It both develops its own branded products and serves as a CDMO-style partner, directly competing with Scapa in hydrocolloid/hydrogel dressings and topical formulations.
• Nitto Denko: Nitto is a global specialty materials company with a significant medical adhesive and transdermal/dermal fixation business serving OEMs in device fixation and wound care. Its technical depth in skin-contact adhesive chemistries and OEM-focused model directly mirrors Scapa's positioning.
• tesa (Beiersdorf): tesa operates a medical business producing adhesive tapes and skin-friendly fixation solutions for medical devices, diagnostics, and wearables. Its specialty adhesive chemistries and OEM-customer model make it a closely comparable peer to Scapa in device fixation.

Broad incumbents

• 3M Health Care: 3M's Health Care division is a large, diversified supplier of medical adhesives, tapes, dressings, and sterilization services, with materially greater R&D and global commercial reach than Scapa. It competes across Scapa's wound care, device fixation, and sterilization capabilities as part of a much broader medical product portfolio.
• ConvaTec: ConvaTec is a major medical products company focused on advanced wound care, ostomy, continence, and critical care. It is a competitor to Scapa in hydrocolloid-based ostomy accessories, advanced wound dressings, and skin barrier technologies, although it operates more as a brand owner than a pure CDMO.
• Coloplast: Coloplast is a global leader in ostomy, wound, continence, and skin care products, with significant R&D and in-house manufacturing capability. It overlaps directly with Scapa in ostomy accessories, hydrocolloid-based skin barriers, and advanced wound dressings.
• Hollister Incorporated: Hollister is a privately held medical products company with a leading ostomy, continence, and wound care portfolio. It directly competes with Scapa in ostomy accessories and skin barrier products, and also manufactures certain fixation and wound care products in-house.
• B. Braun: B. Braun is a global medical device and CDMO with manufacturing depth across IV therapy, wound care, and surgical products. Its contract manufacturing services and vertically integrated production footprint make it a broad but relevant comparator to Scapa's CDMO model.
• Integra LifeSciences: Integra LifeSciences has expanded into advanced wound care and skin/tissue regeneration through acquisitions (including Derma Sciences), and produces specialty wound dressings. It overlaps with Scapa in advanced wound care dressing manufacturing and OEM-style product development for medical channel customers.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/ScapaHealthcare

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Scapa Healthcare